DC, W., S, J., C, B., A, S., R, L., E, L., . . . DA, S. (2018). Adherence rates and health care costs in Crohn's disease patients receiving certolizumab pegol with and without home health nurse assistance: Results from a retrospective analysis of patient claims and home health nurse data. Patient preference and adherence, 12, 869. https://doi.org/10.2147/PPA.S148777
Chicago Style (17th ed.) CitationDC, Wolf, Jaganathan S, Burudpakdee C, Seetasith A, Low R, Lee E, Gucky J, Yassine M, and Schwartz DA. "Adherence Rates and Health Care Costs in Crohn's Disease Patients Receiving Certolizumab Pegol with and Without Home Health Nurse Assistance: Results from a Retrospective Analysis of Patient Claims and Home Health Nurse Data." Patient Preference and Adherence 12 (2018): 869. https://doi.org/10.2147/PPA.S148777.
MLA (9th ed.) CitationDC, Wolf, et al. "Adherence Rates and Health Care Costs in Crohn's Disease Patients Receiving Certolizumab Pegol with and Without Home Health Nurse Assistance: Results from a Retrospective Analysis of Patient Claims and Home Health Nurse Data." Patient Preference and Adherence, vol. 12, 2018, p. 869, https://doi.org/10.2147/PPA.S148777.
